Email updates

Keep up to date with the latest news and content from BMC Cardiovascular Disorders and BioMed Central.

Open Access Research article

Factors associated with shunt dynamic in patients with cryptogenic stroke and patent foramen ovale: an observational cohort study

Christian Tanislav1*, Maximilian Puille2, Mathias Grebe3, Nicole Sieweke1, Jens Allendörfer14, Wolfgang Pabst5, Manfred Kaps1 and Frank Reichenberger6

Author Affiliations

1 Department of Neurology, Justus Liebig University Giessen, Am Steg 14, Giessen, 35392, Germany

2 Department of Nuclear Medicine, Justus Liebig University Giessen, Friedrichstraße 25, 35392, Germany

3 Department of Cardiology, Justus Liebig University Giessen, Klinkstraße 33, Giessen, 35392, Germany

4 Department of Neurology, Neurologische Klinik Bad Salzhausen, Am Hasensprung 6, Nidda, 63667, Germany

5 Institute for Biomedicine and Epidemiology, Justus Liebig University Giessen, Heinrich-Buff-Ring 44, Giessen, 35392, Germany

6 Department of Respiratory Medicine, Justus Liebig University Giessen, Klinkstraße 33, Giessen, 35392, Germany

For all author emails, please log on.

BMC Cardiovascular Disorders 2011, 11:54  doi:10.1186/1471-2261-11-54

Published: 26 August 2011

Abstract

Background

As previously reported there is evidence for a reduction in right to left shunt (RLS) in stroke patients with patent foramen ovale (PFO). This occurs predominantly in patients with cryptogenic stroke (CS). We therefore analysed factors associated with a shunt reduction on follow-up in stroke patients suffering of CS.

Methods

On index event PFO and RLS were proven by transesophageal echocardiography and contrast-enhanced transcranial Doppler-sonography (ce-TCD). Silent PE was proved by ventilation perfusion scintigraphy (V/Q) within the stroke work-up on index event; all scans were re-evaluated in a blinded manner by two experts. The RLS was re-assessed on follow-up by ce-TCD. A reduction in shunt volume was defined as a difference of ≥20 microembolic signals (MES) or the lack of evidence of RLS on follow-up. For subsequent analyses patients with CS were considered; parameters such as deep vein thrombosis (DVT) and silent pulmonary embolism (PE) were analysed.

Results

In 39 PFO patients suffering of a CS the RLS was re-assessed on follow-up. In all patients (n = 39) with CS a V/Q was performed; the median age was 40 years, 24 (61.5%) patients were female. In 27 patients a reduction in RLS was evident. Silent PE was evident in 18/39 patients (46.2%). Factors such as atrial septum aneurysm, DVT or even silent PE were not associated with RLS dynamics. A greater time delay from index event to follow-up assessment was associated with a decrease in shunt volume (median 12 vs. 6 months, p = 0.013).

Conclusions

In patients with CS a reduction in RLS is not associated with the presence of a venous embolic event such as DVT or silent PE. A greater time delay between the initial and the follow-up investigation increases the likelihood for the detection of a reduction in RLS.